glyscend is a company that develops a method of treating metabolic diseases. It aims to provide a non-invasive approach for treating type two diabetes allowing control glucose level and such side effects as gain weight and hypoglycemia. The company creates an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut.